Becton, Dickinson and Co. | BDX - Aktuelle Verpflichtungen

Aktienkurs
154.51
Täglich Wechseln
-1.83 -1.17%
Monatlich
-11.31%
Jährlich
-30.27%
Q2 Prognose
149.86




Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 16.5B 1.91B 2025-12
Agilent USD 2.23B 113M 2025-12
Align Technology USD 1.92B 46.45M 2025-12
AngioDynamics USD 71.96M 3.68M 2025-09
Avanos Medical USD 165.2M 17.3M 2025-12
Baxter International USD 2.97B 805M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Bio-Rad Laboratories USD 517M 5.3M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
Danaher USD 6.81B 483M 2025-12
Dentsply International USD 1.34B 62M 2025-12
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.59B 183.3M 2025-09
Globus Medical USD 498.5M 32.54M 2025-12
Hologic USD 951.3M 25.9M 2025-12
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
Intuitive Surgical USD 2.52B 207.3M 2025-12
J&J USD 54.13B 3.26B 2025-12
Masimo USD 371.6M 1.9M 2025-12
Medtronic USD 9.5B 440M 2025-12
Solventum Corp USD 3.14B 198M 2025-12
Stryker USD 7.79B 380M 2025-12
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
Terumo JPY 539.7B 243.4B 2025-12
Thermo Fisher Scientific USD 15.19B 301M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12